Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661089 · ClinicalTrials.gov registry record · NA
Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00661089 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 21 participants.
The verdict
NCT00661089, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether botulinum toxin type A injected into muscles around the shoulder is effective in treating shoulder pain and improving function in patients with shoulder pain and involuntary muscle tightness after a stroke.
Interventions
- DRUG Placebo (Saline)
- DRUG Botulinum Toxin Type A - OnabotulinumtoxinA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-09 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00661089
The ClinicalTrials.gov registry entry for NCT00661089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo (Saline) is the first listed.
NCT00661089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00661089 about?
NCT00661089 is a clinical study titled "Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity". The purpose of this study is to evaluate whether botulinum toxin type A injected into muscles around the shoulder is effective in treating shoulder pain and improving function in patients with shoulder pain and involuntary muscle tightness after a stroke.
What is the current status of trial NCT00661089?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2003-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00661089?
The interventions under investigation include: Placebo (Saline) (DRUG), Botulinum Toxin Type A - OnabotulinumtoxinA (DRUG).
Who is sponsoring clinical trial NCT00661089?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.